CSat Investment Advisory’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$2K Buy
10
+3
+43% +$485 ﹤0.01% 515
2020
Q4
$1K Sell
7
-14,537
-100% -$2.15M ﹤0.01% 516
2020
Q3
$2.17M Buy
14,544
+369
+3% +$54.6K 0.19% 57
2020
Q2
$1.99M Sell
14,175
-779
-5% -$114K 0.24% 37
2020
Q1
$1.96M Buy
14,954
+4,801
+47% +$681K 0.42% 25
2019
Q4
$1.48M Buy
10,153
+3,080
+44% +$418K 0.39% 45
2019
Q3
$915K Buy
7,073
+1,032
+17% +$136K 0.29% 67
2019
Q2
$842K Buy
6,041
+4,414
+271% +$611K 0.3% 73
2019
Q1
$227K Buy
1,627
+694
+74% +$93K 0.11% 117
2018
Q4
$120K Buy
933
+108
+13% +$15.1K 0.07% 128
2018
Q3
$114K Sell
825
-57
-6% -$7.57K 0.06% 136
2018
Q2
$107K Buy
+882
New +$110K 0.06% 151

Other funds holding JNJ

CSat Investment Advisory's JNJ Position: Q1 2021 in Review

CSat Investment Advisory increased its Johnson & Johnson (JNJ) stake by 43% in Q1 2021, buying an estimated $485 and bringing the position to 10 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #515.

CSat Investment Advisory first reported a position in JNJ in Q2 2018 and has held it in 12 quarters since. The position peaked at $2.17M in Q3 2020. 3,317 funds tracked by Wall St. Rank hold JNJ as of Q1 2021.

  • CSat Investment Advisory held 10 shares of Johnson & Johnson worth $2K as of Q1 2021.
  • CSat Investment Advisory bought 3 Johnson & Johnson shares in Q1 2021, an estimated $485.
  • Johnson & Johnson made up ﹤0.01% of CSat Investment Advisory's portfolio in Q1 2021, its #515 holding.
  • CSat Investment Advisory first reported a position in Johnson & Johnson in Q2 2018 and has held it in 12 quarters since.
  • CSat Investment Advisory's Johnson & Johnson position peaked at $2.17M in Q3 2020.
  • 3,317 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2021.

Based on CSat Investment Advisory's 13F filing for Q1 2021, filed 13 May 2021.